Literature DB >> 24717567

Soft tissue sarcoma, version 2.2014.

Margaret von Mehren1, R Lor Randall, Robert S Benjamin, Sarah Boles, Marilyn M Bui, Ephraim S Casper, Ernest U Conrad, Thomas F Delaney, Kristen N Ganjoo, Suzanne George, Ricardo J Gonzalez, Martin J Heslin, John M Kane, Joel Mayerson, Sean V McGarry, Christian Meyer, Richard J O'Donnell, Alberto S Pappo, I Benjamin Paz, John D Pfeifer, Richard F Riedel, Scott Schuetze, Karen D Schupak, Herbert S Schwartz, Brian A Van Tine, Jeffrey D Wayne, Mary Anne Bergman, Hema Sundar.   

Abstract

These NCCN Guidelines Insights highlight the important updates to the NCCN Guidelines for Soft Tissue Sarcoma (STS) specific to the role of radiation therapy in the management of patients with retroperitoneal/intra-abdominal STS. The guidelines have also included recommendations for genetic testing and counseling for patients with a clinical and/or family history of genetic cancer syndromes associated with a predisposition for the development of STS.

Entities:  

Mesh:

Year:  2014        PMID: 24717567     DOI: 10.6004/jnccn.2014.0053

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  29 in total

1.  Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.

Authors:  Ellen Heitzer; Sandra Sunitsch; Magdalena M Gilg; Birgit Lohberger; Beate Rinner; Karl Kashofer; Nicole Stündl; Peter Ulz; Joanna Szkandera; Andreas Leithner; Bernadette Liegl-Atzwanger
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.

Authors:  Jian-Xian Lin; Qing-Feng Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Chang-Ming Huang
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-12       Impact factor: 4.553

3.  Successful Treatment Toward Gastrointestinal Stromal Tumors with Aggressive Behavior.

Authors:  Landolsi Sana; Mannai Saber
Journal:  J Gastrointest Cancer       Date:  2015-09

4.  The importance of Src signaling in sarcoma.

Authors:  Quanchi Chen; Zifei Zhou; Liancheng Shan; Hui Zeng; Yingqi Hua; Zhengdong Cai
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

Review 5.  Evidence mapping based on systematic reviews of therapeutic interventions for soft tissue sarcomas.

Authors:  M Ballesteros; N Montero; A López-Pousa; G Urrútia; I Solà; G Rada; H Pardo-Hernandez; X Bonfill
Journal:  Clin Transl Oncol       Date:  2019-03-14       Impact factor: 3.405

6.  Mesenteric metastases of purely myxoid liposarcoma: An unusual behavior of primary tumor depicted on fludeoxyglucose positron emission tomography/computerized tomography.

Authors:  Salih Ozguven; Mustafa Aras; Sabahat Inanir
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar

Review 7.  [Pre- or postoperative radiotherapy essential for the treatment of retroperitoneal sarcomas].

Authors:  Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2016-11       Impact factor: 3.621

Review 8.  Management of liver metastases from gastrointestinal stromal tumors: where do we stand?

Authors:  Nikolaos Machairas; Anastasia Prodromidou; Ernesto Molmenti; Ioannis D Kostakis; Georgios C Sotiropoulos
Journal:  J Gastrointest Oncol       Date:  2017-12

Review 9.  Surgical management of retroperitoneal and pelvic sarcomas.

Authors:  Marcus C B Tan; Sam S Yoon
Journal:  J Surg Oncol       Date:  2014-12-05       Impact factor: 3.454

10.  Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

Authors:  Mrinal M Gounder; Alona Zer; William D Tap; Samer Salah; Mark A Dickson; Abha A Gupta; Mary Louise Keohan; Herbert H Loong; Sandra P D'Angelo; Stephanie Baker; Mercedes Condy; Kjirsten Nyquist-Schultz; Lanier Tanner; Joseph P Erinjeri; Francis H Jasmine; Sharon Friedlander; Robert Carlson; Thaddeus J Unger; Jean-Richard Saint-Martin; Tami Rashal; Joel Ellis; Michael Kauffman; Sharon Shacham; Gary K Schwartz; Albiruni Ryan Abdul Razak
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.